A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis

American Journal of Cardiology

Volumn 93, Issue 2, 2004, Pages 259-262

  Goldhaber, Samuel Z ^a   Tapson, Victor F ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; HOSPITAL; HUMAN; HYPERTENSION; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBESITY; PATIENT; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; REGISTER; VASCULAR SURGERY;

EID: 0348223709     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.09.057     Document Type: Article

References (20)

1. Anderson F.A. Jr, Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 151:1991;933-938.
2. Kim V., Spandorfer J. Epidemiology of venous thromboembolic disease. Emerg Med Clin North Am. 19:2001;839-859.
3. Moser K.M., Fedullo P.F., Littejohn J.K., Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA. 271:1994;223-225.
4. Meignan M., Rosso J., Gauthier H., et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with deep venous thrombosis. Arch Intern Med. 160:2000;159-164.
5. Goldhaber S.Z., Visani L., De Rosa M. Acute pulmonary embolism clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) . Lancet. 353:1999;1386-1389.
6. Geerts W.H., Heit J.A., Clagett G.P., Pineo G.F., Colwell C.W., Anderson F.A., Wheeler H.B. Prevention of venous thromboembolism. Chest. 119:(suppl 1):2001;132S-175S.
7. Hansson P.O., Welin L., Tibblin G., Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. "The Study of Men Born in 1913." Arch Intern Med. 157:1997;1665-1670.
8. Oger E., Bressollette L., Nonent M., Lacut K., Guias B., Couturaud F., et al. High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients. Thromb Haemost. 88:2002;592-597.
9. Piccioli A., Prandoni P., Goldhaber S.Z. Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital the Brigham and Women's Hospital DVT registry . Am Heart J. 132:1996;1010-1014.
10. Heit J.A., Melton L.J. III, Lohse C.M., Petterson T.M., Silverstein M.D., Mohr D.N., O'Fallon W.M. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc. 76:2001;1102-1110.
11. Samama M.M., Cohen A.T., Darmon Y.-E., et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med. 341:1999;793-800.
12. Hyers T.M., Agnelli G., Hull R.D., Morris T.A., Samama M., Tapson V., Weg J.G. Antithrombotic therapy for venous thromboembolic disease. Chest. 119:(suppl 1):2001;176S-193S.
13. Spyropoulos A.C., Hurley J.S., Ciesla G.N., de Lissovoy G. Management of acute proximal deep vein thrombosis pharmacoeconomic evaluation of outpatient treatment with unfractionated heparin . Chest. 122:2002;108-114.
14. Harrison L., McGinnis J., Crowther M., Ginsberg J., Hirsh J. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med. 158:1998;2001-2003.
15. Gould M.K., Dembitzer A.D., Doyle R.L., Hastie T.J., Garber A.M. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis a meta-analysis of randomized, controlled trials . Ann Intern Med. 130:1999;800-809.
16. Gould M.K., Dembitzer A.D., Sanders G.D., Garber A.M. Low-molecular-weight heparin for treatment of acute deep venous thrombosis a cost-effectiveness analysis . Ann Intern Med. 130:1999;789-799.
17. Decousus H., Leizorovicz A., Parent F., Page Y., Tardy B., Girard P., et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 338:1998;409-415.
18. White R.H., Zhou H., Kim J., Romano P.S. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med. 160:2000;2033-2041.
19. Centers for Disease Control and Prevention. CDC/nutrition and physical activity. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/ index.htm. Accessed on November 14, 2002.
20. Goldhaber S.Z., Grodstein F., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 277:1997;642-645.